Neal D. Bhatia, MD

Quick facts

Marketed products

• ingenol mebutate 0.05% gel · Dermatology/Oncology
  Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and promote immune-mediated clearance of damaged skin.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Neal D. Bhatia, MD portfolio CI brief
• Neal D. Bhatia, MD pipeline updates RSS